PAI-1
Plasminogen Activator Inhibitor-1 (PAI-1) is a serine protease inhibitor that regulates fibrinolysis by inhibiting tissue plasminogen activator (tPA) and urokinase (uPA). Elevated levels of PAI-1 are associated with an increased risk of thrombosis, cardiovascular diseases, and metabolic syndrome. PAI-1 inhibitors are being investigated for their potential to treat these conditions. At CymitQuimica, we offer PAI-1 inhibitors to support your research in hematology, cardiovascular health, and metabolic diseases.
Found 31 products for "PAI-1".
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
UK-371804 HCl
CAS:UK-371804 is a potent and selective urokinase-type plasmogen activator (uPA) inhibitor with excellent enzyme potency (Ki=10 nM) and selectivity profile (2700-Formula:C14H17Cl2N5O4SPurity:98%Color and Shape:SolidMolecular weight:422.29Diaplasinin
CAS:Diaplasinin (PAI-749) is a potent inhibitor of plasminogen activator inhibitor-1 (PAI-1) with antithrombotic activity, used in cardiovascular disease research.Formula:C32H31N5OPurity:99.75%Color and Shape:Yellow SolidMolecular weight:501.62Ref: TM-T25915
1mg57.00€5mg120.00€1mL*10mM (DMSO)133.00€10mg178.00€25mg409.00€50mg708.00€100mg1,153.00€p-Aminobenzamidine dihydrochloride
CAS:4-Aminobenzamidine dihydrochloride (p-Aminobenzamidine dihydrochloride) is a strong trypsin inhibitor and a relatively weak inhibitor of urokinase typeFormula:C7H11Cl2N3Purity:99.00% - 99.77%Color and Shape:SolidMolecular weight:208.088CT140
CT140 is a human IgG4 monoclonal antibody (mAb) that specifically targets PAI-1. The suggested isotype control for this compound is Human IgG4 kappa, Isotype Control.Color and Shape:Odour LiquidAleplasinin
CAS:Aleplasinin (PAZ 417) is a selective and orally active inhibitor of Plasminogen activator inhibitor-1(PAI-1) and a key negative regulator of the fibrinolyticFormula:C28H27NO3Purity:99.21%Color and Shape:SolidMolecular weight:425.52Ref: TM-T29856
1mg54.00€5mg114.00€1mL*10mM (DMSO)126.00€10mg178.00€25mg409.00€50mg620.00€100mg982.00€200mg1,314.00€AZ3976
CAS:AZ3976 is an inhibitor of PAI-1 with an IC50 of 16 μM in a plasma clot lysis assay. AZ3976 displays profibrinolytic activities.Formula:C15H19N5O3Purity:98.14%Color and Shape:White SolidMolecular weight:317.34ZK824190
CAS:ZK824190: oral uPA inhibitor, IC50 - uPA 237 nM, tPA 1600 nM, Plasmin 1850 nM.Formula:C22H20F2N2O4Purity:98.84%Color and Shape:White SolidMolecular weight:414.4Ref: TM-T13408
1mg152.00€5mg306.00€1mL*10mM (DMSO)318.00€10mg442.00€25mg675.00€50mg900.00€100mg1,224.00€PPACK
CAS:PPACK: synthetic peptide, irreversibly inhibits thrombin (Ki = 0.24 nM), prevents platelet activation.Formula:C21H31ClN6O3Purity:98%Color and Shape:SolidMolecular weight:450.96BT-114143
CAS:BT-114143 is a plasminogen activator inhibitor with an IC50 of 8.42 μM. It is applicable in research related to hemorrhagic diseases caused by excessive fibrinolysis, including traumatic bleeding, severe menorrhagia, postpartum hemorrhage, and complications of hemophilia.Formula:C8H11N2O3PColor and Shape:SolidMolecular weight:214.158GGACK
CAS:GGACK (H-Glu-Gly-Arg-CMK) is an irreversible substrate-like inhibitor of the serine protease urokinase-type plasminogen activator (uPA).Formula:C14H25ClN6O5Color and Shape:SolidMolecular weight:392.84GGACK hydrochloride
GGACK (H-Glu-Gly-Arg-CMK) hydrochloride is an irreversible substrate-like inhibitor of the serine protease urokinase-type plasminogen activator (uPA).Formula:C14H26Cl2N6O5Color and Shape:SolidMolecular weight:428.13417
